- Tulathromycin
-
- $0.00 / 1kg
-
2024-04-08
- CAS:280755-12-6
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 100kg
- Tulathromycin B
-
- $10.00 / 1kg
-
2024-03-08
- CAS:280755-12-6
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 1000kg
- Tulathromycin B
-
- $1760.00 / 1kg
-
2023-12-12
- CAS:280755-12-6
- Min. Order: 1kg
- Purity: 99
- Supply Ability: 1ton
|
| Tulathromycin B Basic information |
Product Name: | Tulathromycin B | Synonyms: | TULATHROMYCIN B;Tulathromycin B, approximately 5% (As a mixture with Tulathromycin A);1-Oxa-4-azacyclotridecan-13-one, 11-[[2,6-dideoxy-3-C-methyl-3-O-methyl-4-C-[(propylamino)methyl]-α-L-ribo-hexopyranosyl]oxy]-2-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-8-hydroxy-3,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, (2R,3R,6R,8R,9R,10S,11S,12R)- (9C...;Tulathromycin B (>95%)
DISCONTINUED, offer T897155;Tulathromycin;(2R,3R,6R,8R,9R,10S,11S,12R)-11-[[2,6-Dideoxy-3-C-methyl-3-O-methyl-4-C-[(propylamino)methyl]-a-L-ribo-hexopyranosyl]oxy]-2-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-8-hydroxy-3,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-1-oxa-4-azacyclotridecan-13-one;Tolamectin B | CAS: | 280755-12-6 | MF: | C41H79N3O12 | MW: | 806.09 | EINECS: | 1806241-263-5 | Product Categories: | 280755-12-6 | Mol File: | 280755-12-6.mol | |
| Tulathromycin B Chemical Properties |
Boiling point | 870.5±65.0 °C(Predicted) | density | 1.17 | storage temp. | -20°C Freezer, Under inert atmosphere | solubility | DMSO (Slightly), Methanol (Slightly) | pka | 13.20±0.70(Predicted) | form | Solid | color | White to Pale Yellow |
| Tulathromycin B Usage And Synthesis |
Uses | Veterinary antibacterial. | Uses | Tulathromycin B is an antibiotic pharmaceutical and also a part of various veterinary compounds. This compound is used for treatment of bacterial and protozoal infections. | Definition | ChEBI: Tulathromycin B is an aminoglycoside. | Veterinary Drugs and Treatments | In beef and non-lactating dairy cattle, tulathromycin is indicated
for the treatment of bovine respiratory disease (BRD) associated
with Mannheimia haemolytica, Pasteurella multocida, Histophilus
somni (Haemophilus somnus) and Mycoplasma bovis; and for the
control of respiratory disease in cattle at high risk of developing
BRD, associated with Mannheimia haemolytica, Pasteurella multocida
and Histophilus somni (Haemophilus somnus).
In swine, tulathromycin is indicated for the treatment of swine
respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae,
Pasteurella multocida, Bordetella bronchiseptica, and
Haemophilus parasuis. |
| Tulathromycin B Preparation Products And Raw materials |
|